{"id":"omoconazole","rwe":[],"tags":[{"label":"omoconazole","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"D01AC13","category":"atc"},{"label":"Active","category":"status"},{"label":"Candidal vulvovaginitis","category":"indication"},{"label":"Candidiasis of skin","category":"indication"},{"label":"Dermatophytosis","category":"indication"},{"label":"Pityriasis versicolor","category":"indication"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antifungal Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["omoconazole","omoconazole nitrate","omoconazole mononitrate","CM-8282"],"offLabel":[],"synonyms":["omoconazole","omoconazole nitrate","omoconazole mononitrate","CM-8282"],"timeline":[],"approvals":[],"ecosystem":[{"indication":"Candidal vulvovaginitis","otherDrugs":[{"name":"butoconazole","slug":"butoconazole","company":"Bayer"},{"name":"clotrimazole","slug":"clotrimazole","company":""},{"name":"fluconazole","slug":"fluconazole","company":"Pfizer"},{"name":"gentian violet","slug":"gentian-violet","company":""}],"globalPrevalence":null},{"indication":"Candidiasis of skin","otherDrugs":[{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ciclopirox","slug":"ciclopirox","company":"Medimetriks Pharms"},{"name":"clotrimazole","slug":"clotrimazole","company":""},{"name":"econazole","slug":"econazole","company":""}],"globalPrevalence":138000000},{"indication":"Dermatophytosis","otherDrugs":[],"globalPrevalence":null},{"indication":"Pityriasis versicolor","otherDrugs":[{"name":"acrisorcin","slug":"acrisorcin","company":"Schering"},{"name":"butenafine","slug":"butenafine","company":"Mylan"},{"name":"carbamide","slug":"carbamide","company":"Hospira"},{"name":"ciclopirox","slug":"ciclopirox","company":"Medimetriks Pharms"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"omoconazole","explanation":"Imagine your body is under attack by tiny fungal invaders. Omoconazole is like a special tool that stops these invaders from growing and multiplying, allowing your body's natural defenses to fight off the infection.","oneSentence":"Omoconazole works by inhibiting the growth of fungal cells.","technicalDetail":"Omoconazole is a triazole antifungal agent that inhibits the cytochrome P450-dependent enzyme lanosterol 14α-demethylase, which is essential for the conversion of lanosterol to ergosterol in fungal cell membranes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1991","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OMOCONAZOLE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:08:25.902756","biosimilars":[],"competitors":[{"drugName":"clotrimazole","drugSlug":"clotrimazole","fdaApproval":"1975-02-03","patentExpiry":"May 26, 2042","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"miconazole","drugSlug":"miconazole","fdaApproval":"1974-01-08","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"econazole","drugSlug":"econazole","fdaApproval":"1982-12-23","patentExpiry":"Aug 8, 2031","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"thiabendazole","drugSlug":"thiabendazole","fdaApproval":"1967-04-07","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"tioconazole","drugSlug":"tioconazole","fdaApproval":"1983-02-18","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketoconazole","drugSlug":"ketoconazole","fdaApproval":"1981-06-12","genericCount":19,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sulconazole","drugSlug":"sulconazole","fdaApproval":"1985-08-30","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"oxiconazole","drugSlug":"oxiconazole","fdaApproval":"1988-12-30","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sertaconazole","drugSlug":"sertaconazole","fdaApproval":"2003-12-10","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"fluconazole","drugSlug":"fluconazole","fdaApproval":"1990-01-29","genericCount":31,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"luliconazole","drugSlug":"luliconazole","fdaApproval":"2013-11-14","patentExpiry":"Sep 6, 2033","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"efinaconazole","drugSlug":"efinaconazole","fdaApproval":"2014-06-06","patentExpiry":"Oct 24, 2030","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"omoconazole","indications":{"approved":[{"name":"Candidal vulvovaginitis","source":"DrugCentral","snomedId":72605008,"regulator":"FDA"},{"name":"Candidiasis of skin","source":"DrugCentral","snomedId":49883006,"regulator":"FDA","usPrevalence":null,"globalPrevalence":138000000,"prevalenceMethod":"curated","prevalenceSource":"Lancet Infect Dis, 2018 (PMID:30078662)"},{"name":"Dermatophytosis","source":"DrugCentral","snomedId":47382004,"regulator":"FDA"},{"name":"Pityriasis versicolor","source":"DrugCentral","snomedId":56454009,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"clotrimazole","brandName":"clotrimazole","genericName":"clotrimazole","approvalYear":"1975","relationship":"same-class"},{"drugId":"miconazole","brandName":"miconazole","genericName":"miconazole","approvalYear":"1974","relationship":"same-class"},{"drugId":"econazole","brandName":"econazole","genericName":"econazole","approvalYear":"1982","relationship":"same-class"},{"drugId":"thiabendazole","brandName":"thiabendazole","genericName":"thiabendazole","approvalYear":"1967","relationship":"same-class"},{"drugId":"tioconazole","brandName":"tioconazole","genericName":"tioconazole","approvalYear":"1983","relationship":"same-class"},{"drugId":"ketoconazole","brandName":"ketoconazole","genericName":"ketoconazole","approvalYear":"1981","relationship":"same-class"},{"drugId":"sulconazole","brandName":"sulconazole","genericName":"sulconazole","approvalYear":"1985","relationship":"same-class"},{"drugId":"oxiconazole","brandName":"oxiconazole","genericName":"oxiconazole","approvalYear":"1988","relationship":"same-class"},{"drugId":"sertaconazole","brandName":"sertaconazole","genericName":"sertaconazole","approvalYear":"2003","relationship":"same-class"},{"drugId":"fluconazole","brandName":"fluconazole","genericName":"fluconazole","approvalYear":"1990","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005693","UNII":"GQ8ADD54E1","CHEBI":"CHEBI:31935","INN_ID":"4991","RXNORM":"134933","UMLSCUI":"C0069488","ChEMBL_ID":"CHEMBL2046550","KEGG_DRUG":"D01664","DRUGBANK_ID":"DB13684","PUBCHEM_CID":"3033988","SNOMEDCT_US":"763190008","SECONDARY_CAS_RN":"83621-06-1","MESH_SUPPLEMENTAL_RECORD_UI":"C050566"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":14,"therapeuticAreas":["Dermatology"],"atcClassification":{"source":"DrugCentral","atcCode":"D01AC13","allCodes":["D01AC13","G01AF16"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"OMOCONAZOLE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Omoconazole is a small molecule antifungal medication developed for the treatment of various fungal infections, including Candidal vulvovaginitis, Candidiasis of skin, Dermatophytosis, and Pityriasis versicolor. The current owner of omoconazole is unknown, and its commercial status is also unclear. As an antifungal agent, omoconazole works by inhibiting the growth of fungal cells, thereby treating the underlying infection. Key safety considerations for omoconazole include unknown half-life and bioavailability, as well as potential side effects that are not well-documented. Further research is needed to fully understand the pharmacokinetics and safety profile of omoconazole.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}